OncoMed Pharmaceuticals Inc Insider Trading for October 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoMed Pharmaceuticals Inc for October 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 4.24 | 1,202 | 5,099 | 68,336 | 69.5 K to 68.3 K (-1.73 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 4.27 | 46 | 196 | 69,538 | 69.6 K to 69.5 K (-0.07 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 4.24 | 1,346 | 5,709 | 76,188 | 77.5 K to 76.2 K (-1.74 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 4.26 | 52 | 222 | 77,534 | 77.6 K to 77.5 K (-0.07 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 4.24 | 1,202 | 5,099 | 70,412 | 71.6 K to 70.4 K (-1.68 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 4.26 | 46 | 196 | 71,614 | 71.7 K to 71.6 K (-0.06 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 4.24 | 1,202 | 5,099 | 80,817 | 82 K to 80.8 K (-1.47 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 4.27 | 46 | 196 | 82,019 | 82.1 K to 82 K (-0.06 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 4.24 | 1,202 | 5,099 | 58,647 | 59.8 K to 58.6 K (-2.01 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Sell | S | 4.26 | 46 | 196 | 59,849 | 59.9 K to 59.8 K (-0.08 %) |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | A | 4.36 | 50,000 | 218,000 | 50,000 | |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Grant | A | 0.00 | 25,000 | 0 | 69,584 | 44.6 K to 69.6 K (+56.07 %) |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | A | 4.36 | 50,000 | 218,000 | 50,000 | |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Grant | A | 0.00 | 25,000 | 0 | 71,660 | 46.7 K to 71.7 K (+53.58 %) |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Option Exercise | A | 4.36 | 36,666 | 159,864 | 36,666 | |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Grant | A | 0.00 | 18,334 | 0 | 59,895 | 41.6 K to 59.9 K (+44.11 %) |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Option Exercise | A | 4.36 | 36,666 | 159,864 | 36,666 | |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Grant | A | 0.00 | 18,334 | 0 | 82,065 | 63.7 K to 82.1 K (+28.77 %) |